InsiderTrades

Form 4 for PRAX Praxis Precision Medicines, Inc.

Accepted 2025-01-14 00:00:00 ET · period of report 2025-01-10 · accession 0001689548-25-000014 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-01-14 2025-01-10 PRAX Kelly Timothy Edwin CFO A - Grant $0.00 +12.5K 24.7K +102% $0
D 2025-01-14 2025-01-12 PRAX Kelly Timothy Edwin CFO F - Tax $63.15 -676 24.0K -3% -$42.7K
D 2025-01-14 2025-01-10 PRAX Kelly Timothy Edwin CFO A - Grant $0.00 +25.0K 25.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-01-10 A A 12,500 $0.00 24,706 D — — (F1) Mr. Kelly was awarded 12,500 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 10, 2025. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
2 Common Common Stock 2025-01-12 F D 676 $63.15 24,030 D — —
3 Derivative Stock Option (Right to Buy) 2025-01-10 A A 25,000 $0.00 25,000 D $63.15 · — to 2035-01-10 25,000 Common Stock (F3) The shares underlying this stock option vest over a four-year period, with 25% vesting on January 10, 2026 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date.